Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arindam Chatterjee

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Plos One|August 12, 2024
Efficacy of pegylated Graphene oxide quantum dots as a nanoconjugate sustained release metformin delivery system in in vitro insulin resistance modelKunal Sarkar, Arindam Chatterjee, Biswabandhu Bankura, et al.
Cancer Cell|June 30, 2015
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and LipogenesisColin A Flaveny, Kristine Griffett, Bahaa El-Dien M El-Gendy, et al.
The Journal of Biological Chemistry|March 2, 2005
Complete inhibition of anisomycin and UV radiation but not cytokine induced JNK and p38 activation by an aryl-substituted dihydropyrrolopyrazole quinoline and mixed lineage kinase 7 small interfering RNAXushan Wang, Mary M Mader, John E Toth, et al.
Journal of Medicinal Chemistry|February 3, 2006
Design, synthesis, and biological activity of novel polycyclic aza-amide FKBP12 ligandsRaymond A Hudack, Nancy S Barta, Chuangxing Guo, et al.
American Journal of Pharmaceutical Education|January 15, 2026
Implementing Standards 2025: Recommendations to Prepare Graduates for Advancements in Practice and Enhance Program QualityMichelle Z Farland, Kathryn J Smith, C Les Ramos, et al.
European Journal of Medicinal Chemistry|July 8, 2023
Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915Carissa S Hampton, Sadichha Sitaula, Cyrielle Billon, et al.
Cell Reports|February 24, 2021
CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibitionAdele M Musicant, Kshitij Parag-Sharma, Weida Gong, et al.
ACS Chemical Biology|March 29, 2023
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise CapacityCyrielle Billon, Sadichha Sitaula, Subhashis Banerjee, et al.
The American Journal of Pathology|September 17, 2023
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging KidneyXiaoxin X Wang, Komuraiah Myakala, Andrew E Libby, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2007
Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38alpha MAP kinase inhibitors with excellent in vivo antiinflammatory propertiesMary Mader, Alfonso de Dios, Chuan Shih, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Plos One|August 12, 2024
Efficacy of pegylated Graphene oxide quantum dots as a nanoconjugate sustained release metformin delivery system in in vitro insulin resistance modelKunal Sarkar, Arindam Chatterjee, Biswabandhu Bankura, et al.
Cancer Cell|June 30, 2015
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and LipogenesisColin A Flaveny, Kristine Griffett, Bahaa El-Dien M El-Gendy, et al.
The Journal of Biological Chemistry|March 2, 2005
Complete inhibition of anisomycin and UV radiation but not cytokine induced JNK and p38 activation by an aryl-substituted dihydropyrrolopyrazole quinoline and mixed lineage kinase 7 small interfering RNAXushan Wang, Mary M Mader, John E Toth, et al.
Journal of Medicinal Chemistry|February 3, 2006
Design, synthesis, and biological activity of novel polycyclic aza-amide FKBP12 ligandsRaymond A Hudack, Nancy S Barta, Chuangxing Guo, et al.
American Journal of Pharmaceutical Education|January 15, 2026
Implementing Standards 2025: Recommendations to Prepare Graduates for Advancements in Practice and Enhance Program QualityMichelle Z Farland, Kathryn J Smith, C Les Ramos, et al.
European Journal of Medicinal Chemistry|July 8, 2023
Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915Carissa S Hampton, Sadichha Sitaula, Cyrielle Billon, et al.
Cell Reports|February 24, 2021
CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibitionAdele M Musicant, Kshitij Parag-Sharma, Weida Gong, et al.
ACS Chemical Biology|March 29, 2023
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise CapacityCyrielle Billon, Sadichha Sitaula, Subhashis Banerjee, et al.
The American Journal of Pathology|September 17, 2023
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging KidneyXiaoxin X Wang, Komuraiah Myakala, Andrew E Libby, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2007
Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38alpha MAP kinase inhibitors with excellent in vivo antiinflammatory propertiesMary Mader, Alfonso de Dios, Chuan Shih, et al.
Pageof 7